Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] NLMUID: 9102551"" wg kryterium: JN


Tytuł :
Coronavirus disease 2019 and coagulopathy: other prothrombotic coagulation factors.
Autorzy :
Calderon-Lopez MT; Department of Hematology and Hemotherapy.
Garcia-Leon N; Department of Hematology and Hemotherapy.
Gomez-Arevalillo S; Department of Haemostasis Laboratory, Central de la Defensa Gomez Ulla Hospital, Madrid, Spain.
Martin-Serrano P; Department of Haemostasis Laboratory, Central de la Defensa Gomez Ulla Hospital, Madrid, Spain.
Matilla-Garcia A; Department of Hematology and Hemotherapy.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2021 Jan 01; Vol. 32 (1), pp. 44-49.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Biomarkers/*blood
Blood Coagulation Disorders/*etiology
COVID-19/*complications
Fibrin Fibrinogen Degradation Products/*adverse effects
Platelet Function Tests/*methods
Adult ; Aged ; Aged, 80 and over ; Anticoagulants/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Effects of rivaroxaban and dabigatran on global hemostasis in patients with atrial fibrillation.
Autorzy :
Petkovic A; Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Al-Khalili F; Department of Clinical Sciences, Danderyds Hospital, Karolinska Insitutet, Stockholm, Sweden.
Antovic A; Division of Rheumatology, Department of Medicine, Karolinska Institutet and Academic Specialist Center, Center for Rheumatology, Stockholm Health Services, Stockholm, Sweden.
Ammar M; Central Clinical School, Monash University.; Department of Gastroenterology, The Alfred, Melbourne, Victoria, Australia.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Pruner I; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Vranic A; Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Soutari N; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
Zdravkovic N; Department of Medical Statistics and Informatics, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Malmström RE; Department of Medicine Solna, Karolinska Institutet & Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.
Jakovljevic V; Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.; Department of Human Pathology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Antovic JP; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2020 Jun; Vol. 31 (4), pp. 243-252.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Atrial Fibrillation/*drug therapy
Dabigatran/*therapeutic use
Hemostasis/*drug effects
Rivaroxaban/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Anticoagulants/pharmacology ; Dabigatran/pharmacology ; Female ; Humans ; Male ; Rivaroxaban/pharmacology
Czasopismo naukowe
Tytuł :
Enzymatic deinduction phenomenon and clinical implications with a focus on direct-acting oral anticoagulants.
Autorzy :
Cole JL; Department of Pharmacy, Veterans Healthcare System of the Ozarks, 1100 North College Avenue, Fayetteville, Arkansas, USA.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2020 Jun; Vol. 31 (4), pp. 283-286.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Drug Interactions/*physiology
Administration, Oral ; Anticoagulants/pharmacology ; Humans
Czasopismo naukowe
Tytuł :
Per oral rat treatment with glyconjugate fractions of Genipa americana leaves protects thrombus formation.
Autorzy :
Madeira JC; Laboratório de Fisio-Farmacologia da Inflamação, Instituto Superior de Ciências Biomédicas.
Farias LAS; Laboratório de Polissacarídeos Bioativos, Faculdade de Educação, Ciências e Letras do Sertão Central, Universidade Estadual do Ceará, Fortaleza, Brazil.
Luz CP; Laboratório de Fisio-Farmacologia da Inflamação, Instituto Superior de Ciências Biomédicas.
Assreuy AMS; Laboratório de Fisio-Farmacologia da Inflamação, Instituto Superior de Ciências Biomédicas.
Pereira MG; Laboratório de Fisio-Farmacologia da Inflamação, Instituto Superior de Ciências Biomédicas.; Laboratório de Polissacarídeos Bioativos, Faculdade de Educação, Ciências e Letras do Sertão Central, Universidade Estadual do Ceará, Fortaleza, Brazil.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2020 Jan; Vol. 31 (1), pp. 107-110.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Plant Leaves/*chemistry
Thrombosis/*drug therapy
Administration, Oral ; Animals ; Anticoagulants/pharmacology ; Rats ; Rats, Wistar
Czasopismo naukowe
Tytuł :
Confounding effect of therapeutic protamine and heparin levels on routine and special coagulation testing.
Autorzy :
Khandelwal A; Fellow, Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Toronto and Canadian Blood Services, Toronto.
Phua CW; Division of Hematology, Department of Medicine, London Health Sciences Centre, London.
Chaudhry HR; Department of Hematology and Laboratory Medicine, St. Michael's Hospital, Toronto.
Tsui H; Hematological Pathology, Department of Laboratory Hematology, Toronto General Hospital, University Health Network, Toronto, Ontario.
Rivard GE; Department of Hematology-Oncology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec.
Teitel JM; Division of Hematology, Department of Medicine, St. Michael's Hospital.
Sholzberg M; Division of Hematology, Departments of Medicine and Laboratory Medicine & Pathobiology, St. Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2020 Jan; Vol. 31 (1), pp. 60-64.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Blood Coagulation/*drug effects
Blood Coagulation Tests/*methods
Heparin/*therapeutic use
Protamines/*therapeutic use
Anticoagulants/pharmacology ; Heparin/pharmacology ; Humans ; Middle Aged ; Protamines/pharmacology
Czasopismo naukowe
Tytuł :
Evaluation of biomarkers for monitoring thrombogenic potential of FXaI16L.
Autorzy :
Bolt MW; Drug Safety Research and Development.
Hua F; Rare Disease Research Unit, Pfizer Inc, Cambridge, Massachusetts.
Brenneman KA; Drug Safety Research and Development.
Graves JE; Drug Safety Research and Development.
Arkin S; Rare Disease Research Unit, Pfizer Inc, Cambridge, Massachusetts.
Criswell K; Clinical Research Unit, Pfizer, Inc., Groton, Connecticut, USA.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2020 Jan; Vol. 31 (1), pp. 16-28.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Biomarkers/*metabolism
Blood Coagulation Tests/*methods
Factor Xa/*therapeutic use
Thrombosis/*drug therapy
Animals ; Anticoagulants/pharmacology ; Factor Xa/pharmacology ; Haplorhini ; Humans ; Mice ; Rats ; Rats, Wistar
Czasopismo naukowe
Tytuł :
Thrombin generation test with the calibrated automated thrombogram and anticoagulant activity of Mentha crispa.
Autorzy :
Leite PM; Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Miranda APN
Amorim JM
Duarte RCF
Faraco AAG
Carvalho MDG
Castilho RO
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2020 Jan; Vol. 31 (1), pp. 101-106.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Blood Coagulation/*drug effects
Blood Coagulation Tests/*methods
Mentha/*chemistry
Anticoagulants/pharmacology ; Healthy Volunteers ; Humans
Czasopismo naukowe
Tytuł :
Argatroban to achieve therapeutic anticoagulation in two patients with acute thrombosis and heparin resistance.
Autorzy :
Mindlina I; School of Clinical Medicine, University of Cambridge.
Nelmes E; School of Clinical Medicine, University of Cambridge.
Sharp M; Department of Haematology.
Butler A; Department of Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Gudgin E; Department of Haematology.
Thomas W; Department of Haematology.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2019 Dec; Vol. 30 (8), pp. 426-428.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Pipecolic Acids/*therapeutic use
Thrombosis/*drug therapy
Acute Disease ; Adult ; Arginine/analogs & derivatives ; Drug Resistance ; Female ; Heparin/pharmacology ; Humans ; Male ; Middle Aged ; Sulfonamides
Czasopismo naukowe
Tytuł :
Anticoagulant activity of krait, coral snake, and cobra neurotoxic venoms with diverse proteomes are inhibited by carbon monoxide.
Autorzy :
Nielsen VG; The Department of Anesthesiology, University of Arizona College of Medicine, Tucson, Arizona.
Frank N; Mtoxins, Oshkosh, Wisconsin, USA.
Turchioe BJ; The Department of Anesthesiology, University of Arizona College of Medicine, Tucson, Arizona.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2019 Dec; Vol. 30 (8), pp. 379-384.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants*
Carbon Monoxide/*pharmacology
Snake Venoms/*pharmacology
Animals ; Blood Coagulation/drug effects ; Blood Specimen Collection ; Bungarotoxins/antagonists & inhibitors ; Bungarotoxins/chemistry ; Bungarotoxins/pharmacology ; Bungarus ; Coral Snakes ; Elapid Venoms/antagonists & inhibitors ; Elapid Venoms/chemistry ; Elapid Venoms/pharmacology ; Elapidae ; Humans ; Neurotoxins/antagonists & inhibitors ; Proteome/analysis ; Snake Venoms/antagonists & inhibitors ; Snake Venoms/chemistry ; Thrombelastography
Czasopismo naukowe
Tytuł :
A case-report of successful use of thromboelastography to manage anticoagulation therapy in a patient with concomitant catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia.
Autorzy :
Nguyen B; University of Florida College of Medicine.
Hernandez MDMM; University of Florida College of Medicine.
Baldeo C; University of Florida College of Medicine.
Cury J; University of Florida College of Medicine.
Ferreira JA; University of Florida Health Jacksonville, Jacksonville, Florida, USA.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2019 Jun; Vol. 30 (4), pp. 171-175.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Antiphospholipid Syndrome/*complications
Thrombelastography/*methods
Thrombocytopenia/*complications
Antithrombins/therapeutic use ; Catastrophic Illness ; Disease Management ; Heparin/adverse effects ; Humans ; Thrombocytopenia/chemically induced ; Thrombosis/diagnosis
Czasopismo naukowe
Tytuł :
Efficacy of direct oral anticoagulants on left ventricular thrombus.
Autorzy :
Turgay Yildirim Ö; Department of Cardiology, Eskisehir State Hospital, Eskisehir.
Akşit E; Department of Cardiology, Canakkale Onsekiz Mart University, Çanakkale, Turkey.
Aydin F; Department of Cardiology, Eskisehir State Hospital, Eskisehir.
Hüseyinoğlu Aydin A; Department of Cardiology, Eskisehir State Hospital, Eskisehir.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2019 Apr; Vol. 30 (3), pp. 96-103.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Anticoagulants/*therapeutic use
Heart Ventricles/*pathology
Thrombosis/*drug therapy
Administration, Oral ; Humans ; Myocardial Infarction/complications ; Thrombosis/etiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Novel isomeric metabolite profiles correlate with warfarin metabolism phenotype during maintenance dosing in a pilot study of 29 patients.
Autorzy :
Pouncey DL; Department of Chemistry, Hendrix College, Conway, Arkansas, USA.; Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Hartman JH; Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Moore PC; Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Dillinger DJ; Department of Pharmacy, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA.
Dickerson KW; Department of Pharmacy, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA.
Sappington DR; Department of Environmental and Occupational Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Smith ES 3rd; Department of Medicine, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA.
Boysen G; Department of Environmental and Occupational Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Miller GP; Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2018 Nov; Vol. 29 (7), pp. 602-612.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*metabolism
Warfarin/*metabolism
Aged ; Cohort Studies ; Female ; Humans ; Male ; Phenotype ; Pilot Projects
Czasopismo naukowe
Tytuł :
Clinical and genetic factors influencing acenocoumarol dosing: a cross-sectional study.
Autorzy :
Vázquez C; Clinical Pharmacology Section, Internal Medicine Department.
Orlova M; Clinical Pharmacology Section, Internal Medicine Department.
Scibona P; Clinical Pharmacology Section, Internal Medicine Department.; Instituto de Ciencias Básicas y Medicina Experimental (ICBME), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Ferreyro BL; Interdepartmental Division of Critical Care Medicine, University Health Network/Mount Sinai Hospital, Toronto, Ontario, Canada.
Otero V; Hematology Section, Internal Medicine Department. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Jáuregui EG; Clinical Pharmacology Section, Internal Medicine Department.
Arbelbide J; Hematology Section, Internal Medicine Department. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Belloso WH; Clinical Pharmacology Section, Internal Medicine Department.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2018 Sep; Vol. 29 (6), pp. 496-500.
Typ publikacji :
Journal Article
MeSH Terms :
Acenocoumarol/*therapeutic use
Anticoagulants/*therapeutic use
Acenocoumarol/administration & dosage ; Aged ; Aged, 80 and over ; Anticoagulants/administration & dosage ; Cross-Sectional Studies ; Cytochrome P-450 CYP2C9/genetics ; Cytochrome P450 Family 4/genetics ; Dose-Response Relationship, Drug ; Female ; Genotype ; Haplotypes ; Humans ; Male ; Middle Aged ; Pharmacogenomic Testing ; Vitamin K Epoxide Reductases/genetics
Czasopismo naukowe
Tytuł :
Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography.
Autorzy :
Gantioqui J; Thrombosis and Atherosclerosis Research Institute.; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Stevic I; Thrombosis and Atherosclerosis Research Institute.; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Atkinson H; Thrombosis and Atherosclerosis Research Institute.; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Chan AKC; Thrombosis and Atherosclerosis Research Institute.; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2018 Sep; Vol. 29 (6), pp. 521-527.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*pharmacology
Blood Coagulation/*drug effects
Blood Platelets/*drug effects
Dabigatran/*pharmacology
Heparin/*pharmacology
Rivaroxaban/*pharmacology
Blood Coagulation Tests ; Humans ; Thrombelastography/methods
Czasopismo naukowe
Tytuł :
Management of heavy menstrual bleeding during direct oral anticoagulant therapy for recurrent venous thromboembolism: a case report.
Autorzy :
Giustozzi M; Vascular and Emergency Medicine and Stroke Unit, University of Perugia, Perugia, Italy.
Vedovati MC
Agnelli G
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2018 Jun; Vol. 29 (4), pp. 391-394.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anticoagulants/*adverse effects
Menorrhagia/*chemically induced
Venous Thromboembolism/*complications
Anticoagulants/therapeutic use ; Disease Management ; Female ; Gonadotropin-Releasing Hormone/agonists ; Humans ; Middle Aged ; Progestins/therapeutic use ; Recurrence ; Rivaroxaban/adverse effects ; Rivaroxaban/therapeutic use ; Treatment Outcome ; Venous Thromboembolism/drug therapy
Czasopismo naukowe
Tytuł :
Thrombin generation estimates the anticoagulation effect of direct oral anticoagulants with significant interindividual variability observed.
Autorzy :
Rigano J; Austin Pathology, Austin Health, Heidelberg.
Ng C; Department of Clinical Haematology, Northern Health, Epping.
Nandurkar H; Australian Centre for Blood Disease, Monash University, Melbourne, Victoria, Australia.
Ho P; Department of Clinical Haematology, Northern Health, Epping.; Florey Institute of Neuroscience and Mental Health, Parkville.; Australian Centre for Blood Disease, Monash University, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2018 Mar; Vol. 29 (2), pp. 148-154.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Thrombin/*therapeutic use
Warfarin/*therapeutic use
Administration, Oral ; Humans ; Thrombin/pharmacology ; Warfarin/pharmacology
Czasopismo naukowe
Tytuł :
Oral anticoagulation cost in primary antiphospholipid syndrome: comparison between warfarin and hypothetical rivaroxaban.
Autorzy :
Ciampa A; Haemostasis Unit, San Giuseppe Moscati Hospital, Avellino, Italy.
Salapete C; Haemostasis Unit, San Giuseppe Moscati Hospital, Avellino, Italy.
Vivolo S; Haemostasis Unit, San Giuseppe Moscati Hospital, Avellino, Italy.
Ames PRJ; Immune Response and Vascular Disease Unit, CEDOC, Nova Medical School/Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal.; Department of Haematology, Dumfries Royal Infirmary, Dumfries, UK.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2018 Jan; Vol. 29 (1), pp. 135-138.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Antiphospholipid Syndrome/*drug therapy
Factor Xa Inhibitors/*therapeutic use
Administration, Oral ; Anticoagulants/pharmacology ; Antiphospholipid Syndrome/pathology ; Factor Xa Inhibitors/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Rivaroxaban/pharmacology ; Rivaroxaban/therapeutic use ; Warfarin/pharmacology ; Warfarin/therapeutic use
Czasopismo naukowe
Tytuł :
Complete antithrombin replacement for anticoagulation for cardiopulmonary bypass to repair severe infective mitral valve endocarditis.
Autorzy :
Yu S; Department of Anesthesiology.
Khalpey ZI; Department of Surgery.
Wong RK; Department of Pharmacology, The University of Arizona College of Medicine, Tucson, Arizona, USA.
Huynh T; Department of Pharmacology, The University of Arizona College of Medicine, Tucson, Arizona, USA.
Nielsen VG; Department of Anesthesiology.
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2018 Jan; Vol. 29 (1), pp. 123-125.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Antithrombin III/*therapeutic use
Blood Coagulation Tests/*methods
Cardiopulmonary Bypass/*methods
Endocarditis/*surgery
Mitral Valve/*surgery
Adult ; Anticoagulants/pharmacology ; Antithrombin III/pharmacology ; Cardiopulmonary Bypass/adverse effects ; Endocarditis/pathology ; Humans ; Male
Czasopismo naukowe
Tytuł :
Non-vitamin K antagonist oral anticoagulants in patients with severe inherited thrombophilia: a series of 33 patients.
Autorzy :
Undas A; aInstitute of Cardiology, Jagiellonian University Medical College bJohn Paul II Hospital, Cracow, Poland.
Goralczyk T
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2017 Sep; Vol. 28 (6), pp. 438-442.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*therapeutic use
Thrombophilia/*drug therapy
Venous Thromboembolism/*drug therapy
Adult ; Dabigatran/therapeutic use ; Female ; Humans ; Male ; Medication Adherence ; Middle Aged ; Pyrazoles/therapeutic use ; Pyridones/therapeutic use ; Recurrence ; Rivaroxaban/therapeutic use ; Thrombophilia/complications ; Venous Thromboembolism/etiology ; Young Adult
SCR Disease Name :
Thrombophilia, hereditary
Czasopismo naukowe
Tytuł :
Concerns about andexanet.
Autorzy :
Stöllberger C; a2nd Medical Department, Krankenanstalt Rudolfstiftung, Vienna, Austria bMedizinische Klinik II, Sana Kliniken Lübeck, Lübeck, Germany.
Schneider B
Pokaż więcej
Źródło :
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2017 Jun; Vol. 28 (4), pp. 275.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Anticoagulants*
Factor Xa Inhibitors*
Administration, Oral ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies